|
1
|
Tharavichitkul E. SP-122: Thailand 3D MRI brachy in Chiang Mai: Fairytale story from a 'provincial hospital in Thailand to a Embrace triallist center. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(20)30612-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
|
2
|
Chopra S, Mittal P, Viswanathan A, Tharavichitkul E, Zubizarreta E, Nout RA, Yap ML, Grover S, Rodin D, Rai B, Gondhowiardjo S, Shrivastava SK. Global Collaborations for Cervical Cancer: Can the East-West Alliance Facilitate Treatment for all? Clin Oncol (R Coll Radiol) 2019; 31:529-538. [PMID: 31229379 DOI: 10.1016/j.clon.2019.05.022] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2019] [Revised: 05/11/2019] [Accepted: 05/28/2019] [Indexed: 12/20/2022]
Abstract
Despite the advances in the primary prevention of cervical cancer, there is an absolute increase in the incidence of cervical cancer as a result of an increase in world population. A vast majority of patients in low and low-middle income countries continue to present at a locally advanced stage, necessitating treatment with chemoradiation and brachytherapy. There is a dearth of equipment and trained professionals for the treatment of cervical cancer, especially in low and low-middle income countries. There is an urgent need to improve treatment availability and develop better treatments. Worldwide trends, however, reveal a low number of therapeutic and innovative research trials in cervical cancer. The present article elucidates the existing challenges and provides solutions to improve outcomes. The proposed strategies hinge on strengthening collaborations for global advocacy.
Collapse
Affiliation(s)
- S Chopra
- Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India; Homi Bhabha National Institute, Mumbai, India.
| | - P Mittal
- Homi Bhabha National Institute, Mumbai, India; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - A Viswanathan
- Department of Radiation Oncology, Johns Hopkins University Medical Center, Baltimore, Maryland, USA
| | - E Tharavichitkul
- Division of Radiation Oncology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
| | - E Zubizarreta
- Division of Human Health, International Atomic of Energy Agency - Vienna International Centre, Vienna, Austria
| | - R A Nout
- Department of Radiation Oncology, Leiden University Medical Center LUM, Leiden, the Netherlands
| | - M L Yap
- Collaboration for Cancer Outcomes, Research and Evaluation (CCORE), Ingham Institute, UNSW Sydney, Liverpool, New South Wales, Australia; Liverpool and Macarthur Cancer Therapy Centres, Western Sydney University, Campbelltown, New South Wales, Australia; School of Public Health, The University of Sydney, Camperdown, Australia
| | - S Grover
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA; Botswana-UPENN Partnership, University of Botswana, Gaborone, Botswana
| | - D Rodin
- Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
| | - B Rai
- Postgraduate Institute of Medical Education and Research, Chandigarh, India
| | - S Gondhowiardjo
- Department of Radiotherapy, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
| | - S K Shrivastava
- Department of Radiation Oncology, Apollo Hospital, Belapur, Navi Mumbai, India
| |
Collapse
|
|
3
|
Tharavichitkul E, Chakrabandhu S, Klunklin P, Onchan W, Supawongwattana B, Pukanhaphan N, Galalae R, Chitapanarux I. 275P Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma for general condition patients: a single institution experience from Thailand. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv525.09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
4
|
Chakrabandhu S, Chitapanarux I, Onchan W, Klunklin P, Supawongwattana B, Tharavichitkul E, Lorvidhaya V. OP0005 Neoadjuvant chemotherapy plus chemoradiation (NACT-CCRT) versus chemoradiation plus adjuvant chemotherapy (CCRT-ACT) for locally advanced nasopharyngeal cancer: 3-Year results from a randomised trial. Eur J Cancer 2015. [DOI: 10.1016/j.ejca.2015.06.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
|
5
|
Tharavichitkul E, Samakgarn V, Tharavichitkul E, Chakrabandhu S, Klunklin P, Onchan W, Supawongwattana B, Pukanhaphan N, Chitapanarux I. P0031 Use of FOLFOX4 regimen in stage IV cervical cancer: A pilot study. Eur J Cancer 2015. [DOI: 10.1016/j.ejca.2015.06.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
|
6
|
Sturdza A, Lindegaard J, Fokdal L, Nkiwane K, Chitapanarux I, de Leeuw A, Gillham C, Haie-Meder C, Hoskin P, Hudej R, Janssen H, Jürgenliemk-Schulz I, Lowe G, Mazeron R, McArdle O, Petric P, Tharavichitkul E, van Limbergen E, Kirisits C, Tanderup K, Pötter R. 53 speaker RETRO-EMBRACE: PRELIMINARY RESULTS OF IMAGE GUIDED BT FOR CERVICAL CANCER IN THE LAST YEARS OF THE 20ST CENTURY. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)70176-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
|
7
|
Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, Tharavichitkul E, Sittitrai P, Pattarasakulchai T, Tananuwat R, Srivanitchapoom C, Sukthomya V. 8562 Phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71653-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
|
8
|
Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, Tharavichitkul E, Trakultivakorn H, Somwangprasert A, Sumitsawan S. Gemcitabine plus cisplatin (GC): A salvage regimen for breast cancer patients who failed anthracycline and/or taxanes. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.757] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
|
9
|
Chitapanarux I, Lorvidhaya V, Kamnerdsupaphon P, Sumitsawan Y, Katanyoo K, Tharavichitkul E, Pukanhapan N. 113 Preliminary results of a prospective randomized study of chemoradiation comparing cisplatin vs carboplatin in locally advanced nasopharyngeal cancer. EJC Suppl 2003. [DOI: 10.1016/s1359-6349(03)90146-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|